COVID-19 vaccines for low- and middle-income countries
E Choi
2021Transactions of the Royal Society of Tropical Medicine and Hygiene93 citationsDOIOpen Access PDF
Abstract
The COVID-19 pandemic is the biggest threat to public health in a century. Through hard work and ingenuity, scientists have developed a number of safe and effective vaccines against COVID-19 disease. However, demand far outstrips supply and countries around the world are competing for available vaccines. This review describes how low- and middle-income countries access COVID-19 vaccines, what is being done to distribute vaccines fairly, as well as the challenges ahead.
Topics & Concepts
IngenuityCoronavirus disease 2019 (COVID-19)PandemicLow and middle income countries2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public healthWork (physics)Developing countryBusinessVirologyEconomic growthMedicineDiseaseInfectious disease (medical specialty)EconomicsOutbreakEngineeringNursingMechanical engineeringPathologyNeoclassical economicsSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 epidemiological studies